Report copyright - Summary of Safety and Effectivness (SSED)Template · 16/6/2020 · PIQRAY® (alpelisib) in breast cancer patients with PIK3CA alterations was approved on December 3, 2019. PMA supplement
Please pass captcha verification before submit form